Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Minutes of a Eileen Trust Board meeting noted that the Board did not consider that support from the Trust should necessarily be secondary to that from state benefits.
Published on:
24 July, 2024
A scheme of payments for those "infected with HIV through blood or tissue transfer" in England, Wales and Northern Ireland was set up on 24 April 1992. It provided for the payment of fixed sums to people infected and "infected intimates" in different categories, depending on whether they were adult or younger, were married, and whether they had dependent children.
Published on:
24 July, 2024
Peter Stevens stated in his oral evidence that the Eileen Trust always suggested to registrants to try other fund options so that the Eileen Trust was a fallback.
Published on:
24 July, 2024
Although the Eileen Trust was administered by the same people as administered the MacFarlane Trust, the Eileen Trust's Board made the decisions which it thought best for the Eileen Trust and did not strictly follow the MacFarlane Trust's policies.
Published on:
24 July, 2024
Regular contact with office staff and case workers allowed registrants of the Eileen Trust to know what they could apply for and although there were subsequent handbooks that were budgeted to be produced from 2002 - 2011, from around 2001/02 the Board decided that newsletters and speaking to caseworkers were the best way to keep in contact with registrants.
Published on:
24 July, 2024
Following an "Away Day" with MacFarlane Trust trustees, Peter Stevens reported the feedback from this to the Eileen Trust Board that financial need must be a prerequisite for any disbursement by a charity.
Published on:
24 July, 2024
An article titled "Percutaneous Liver Biopsy and Chronic Liver Disease in Haemophiliacs" was published in The Lancet. It asserted that the high incidence of chronic liver disease was related to concentrate replacement therapy.
Published on:
24 July, 2024
In a letter from Dr Walford, it was emphasised that 90% of all post-transfusion hepatitis in the USA and elsewhere was caused by non-A, non-B hepatitis viruses. It was described as rapidly fatal.
Published on:
24 July, 2024
An article titled "Non-A, Non-B Hepatitis Associated With Chronic Liver Disease in a Haemodialysis Unit" in The Lancet described NANB hepatitis as relating to "high frequency of persistent hepatic dysfunction".
Published on:
24 July, 2024
In an article titled "Transfusion-associated hepatitis not due to viral hepatitis type A or B" it was recognised NANB hepatitis was the cause of many cases of post-transfusion hepatitis in comparison to other types.
Published on:
24 July, 2024
An article in the The Lancet titled "Non-A Non-B Hepatitis Post Transfusion Hepatitis", contained data that pointed to NANBH being the cause of a substantial cases of post-transfusion hepatitis.
Published on:
24 July, 2024
An article in The Yale Journal of Biology and Medicine titled, "Non-A, Non-B Hepatitis", outlined the role of NANB of subsequent development of chronic liver disease.
Published on:
24 July, 2024
An article in Gastroenterology titled, "Development of Chronic Liver Disease after Acute Non-A, Non-B Post-Transfusion Hepatitis: Role of _-globulin prophylaxis in its prevention", outlined the role of NANB of subsequent development of chronic liver disease.
Published on:
24 July, 2024
Article in Gastroenterology titled, "Post-transfusion hepatitis: The role of hepatitis B antibody", outlined the role of NANB of subsequent development of chronic liver disease.
Published on:
24 July, 2024
An article titled, "Non-A/Non-B Hepatitis: A Review and Interim Report of an Ongoing Prospective Study", outlined the role of NANB of subsequent development of chronic liver disease.
Published on:
24 July, 2024
In an article in The British Medical Journal titled, "Post-transfusion non-A, non-B hepatitis in the Netherlands", the significance of NANBH and the need for a test for it was outlined.
Published on:
24 July, 2024
Peter Burgin, senior executive officer at the Department of Health, was recruited to carry out the formal internal review on self-sufficiency. The material parts of the job were set out in the job description.
Published on:
25 July, 2024
Richard Gutowski, Head of Blood Policy, expressed the view external resources were needed to finalise the report on self-sufficiency.
Published on:
11 October, 2024
The version of the self-sufficiency report as amended by Dianthus Medical Ltd was sent to Richard Gutowski, Head of Blood Policy..
Published on:
25 July, 2024
Peter Burgin carried out a number of interviews as part of his review on self-sufficiency, including Dr Terry Snape, Blood Products Laboratory. Dr Snape prepared various documents for Peter Burgin prior to his visit.
Published on:
25 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2045
Page
2046
Page
2047
Page
2048
Current page
2049
Page
2050
Page
2051
Page
2052
Page
2053
…
Next page
Next
Last page
Last